Katja Harbst
Lund University(SE)Medicon Village(SE)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses
Most-Cited Works
- → Tertiary lymphoid structures improve immunotherapy and survival in melanoma(2020)2,253 cited
- → Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer(2015)494 cited
- → Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma(2017)486 cited
- → Pervasive chromosomal instability and karyotype order in tumour evolution(2020)396 cited
- → A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population(2010)341 cited
- → Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy(2015)191 cited
- → NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics(2017)132 cited
- → Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers(2009)115 cited
- → Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma(2012)108 cited
- → The clinical significance ofBRAFandNRASmutations in a clinic-based metastatic melanoma cohort(2013)105 cited